ReviewChemMedChem2026
Chemical Optimization of Temporin A-L Peptides: From Native Isoforms to Enhanced Antimicrobial Analogs.
Review in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporins A-L, a family of short antimicrobial peptides isolated from the skin secretions of Rana temporaria, have emerged as promising scaffolds for the development of novel anti-infective agents. However, their therapeutic translation is limited by issues such as modest selectivity, susceptibility to proteolytic degradation, and variable potency. In this review, we provide an overview of the medicinal chemistry efforts devoted to the optimization of this class of AMPs through systematic chemical modifications. Strategies including backbone alterations (e.g., D-amino acid incorporation and retro-inverso design), side chain modulation, charge tuning, hydrophobicity adjustment, and the introduction of noncanonical residues are discussed in relation to their impact on antimicrobial activity and selectivity. Particular attention is given to conformationally constrained analogs, such as cyclic, stapled, and bicyclic derivatives, which often display enhanced stability and bioactivity. By integrating available data, we delineated key structure-activity relationships governing temporin function and identified emerging design principles for the development of improved analogs. Finally, current challenges and future perspectives for the advancement of temporin-based therapeutics in medicinal chemistry are outlined.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.